The DCBLD2 Polyclonal Antibody (PAC016145) is the ideal tool for researchers studying DCBLD2, a cell surface protein involved in various cellular processes, including angiogenesis and cancer progression. This antibody, produced in rabbits, demonstrates high reactivity with human samples and is validated for use in Western blot applications. By binding specifically to the DCBLD2 protein, this antibody facilitates the detection and analysis of DCBLD2 in different cell types, making it a valuable asset for studies in cancer biology and vascular development.
DCBLD2, also known as ESDN, has been implicated in promoting tumor growth and metastasis in several types of cancer. Its role in angiogenesis and cell migration suggests its potential as a therapeutic target for cancer treatment. By understanding the function of DCBLD2, researchers may uncover new insights into tumor progression and identify novel strategies for inhibiting cancer spread. The DCBLD2 Polyclonal Antibody is a valuable tool for unraveling the biological mechanisms underlying DCBLD2-mediated processes and advancing cancer research.
Antibody Name:
DCBLD2 Antibody (PACO16145)
Antibody SKU:
PACO16145
Size:
50ul
Host Species:
Rabbit
Tested Applications:
ELISA, IHC
Recommended Dilutions:
ELISA:1:2000-1:10000, IHC:1:100-1:300
Species Reactivity:
Human, Mouse, Rat
Immunogen:
Fusion protein of human DCBLD2
Form:
Liquid
Storage Buffer:
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Purification Method:
Antigen affinity purification
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using PACO16145(DCBLD2 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: x200).
The image on the left is immunohistochemistry of paraffin-embedded Human gastic cancer tissue using PACO16145(DCBLD2 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: x200).
Background:
CLCP1 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1), also known as DCBLD2 (discoidin, CUB and LCCL domain containing 2) or ESDN, is a 775 amino acid, single-pass type I membrane protein that contains one CUB domain, one LCCL domain and one F5/8 type C domain. Expressed at high levels in heart, testis and skeletal muscle, CLCP1 is thought to regulate vascular smooth muscle cell (VSMC) proliferation and remodeling and may be involved in the transformation and metastasis of various cancers, such as metastatic lung cancer and gastric carcinoma.
Synonyms:
discoidin, CUB and LCCL domain containing 2
UniProt Protein Function:
DCBLD2: a type-I transmembrane protein. May be involved in vascular remodeling and influence vascular smooth muscle cell proliferation. Contains a CUB domain and a coagulation factor V/VIII homology domain, similar to the structure of the neuropilins. Plays a role in cell motility. SEMA4B appears to be one of its ligands. Strongly expressed in nerve bundles. Highly expressed in testis, heart, skeletal muscle and also in cultured vascular smooth muscle cells. Increased in lung cancers during the process of tumor progression. A target of EGF signaling in the A431 cervical cancer cell-line. Two isoforms of the human protein are produced by alternative splicing.Protein type: Cell adhesion; Membrane protein, integralChromosomal Location of Human Ortholog: 3q12.1|3Cellular Component: cell surface; integral to plasma membraneMolecular Function: protein bindingBiological Process: negative regulation of cell growth; wound healing